IDXX FY 2023 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

FY 2023 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$3.7B+8.7% YoY

Gross Profit

$2.2B59.8% margin

Operating Income

$1.1B30.0% margin

Net Income

$845M23.1% margin

EPS (Diluted)

$10.06

Cash Flow

Operating Cash Flow

$907M

Free Cash Flow

$773M

Stock-Based Comp.

$60M

Balance Sheet

Total Assets

$3.3B

Total Liabilities

$1.8B

Stockholders' Equity

$1.5B

Cash & Equivalents

$454M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.7B	$3.4B	+8.7%
Gross Profit	$2.2B	$2.0B	+9.3%
Operating Income	$1.1B	$899M	+22.1%
Net Income	$845M	$679M	+24.4%